摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-2-phenyl-6,7-dihydro-[1,3,4]thiadiazolo[3,2-α][1,3]diazepin-8(5H)-one | 1402423-91-9

中文名称
——
中文别名
——
英文名称
(E)-2-phenyl-6,7-dihydro-[1,3,4]thiadiazolo[3,2-α][1,3]diazepin-8(5H)-one
英文别名
2-phenyl-6,7-dihydro-[1,3,4]thiadiazolo[3,2-a][1,3]diazepin-8(5H)-one;G5-62;(E)-2-phenyl-6,7-dihydro-[1,3,4]thiadiazolo[3,2-a][1,3]diazepin-8(5H)-one;2-Phenyl-6,7-dihydro-[1,3,4]thiadiazolo[3,2-alpha][1,3]diazepin-8(5H)-one;2-phenyl-6,7-dihydro-5H-[1,3,4]thiadiazolo[3,2-a][1,3]diazepin-8-one
(E)-2-phenyl-6,7-dihydro-[1,3,4]thiadiazolo[3,2-α][1,3]diazepin-8(5H)-one化学式
CAS
1402423-91-9
化学式
C12H11N3OS
mdl
——
分子量
245.305
InChiKey
JVSDFZACAGIJEC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    70.3
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    参考文献:
    名称:
    新型短效催眠药HIE-124的噻二唑[3,2- a ] [1,3]二氮杂analogue类似物的合成,生物学评价和分子建模研究
    摘要:
    合成了一系列新的6,7-二氢-[1,3,4]噻二唑[3,2- a ] [1,3]二氮杂analogue类似物,并对其进行了生物学评估。与硫喷妥钠(6)相比,化合物GS-62(33)表现出强大的体内短效催眠活性,其起效时间,睡眠时间和治疗指数分别为6.4±0.2、94.8±5.3分钟,6.62 。维持剂量为6时,化合物33没有显示出任何急性耐受的迹象。同时33增强了6的体内催眠作用等摩尔量(0.06 mmol)的组合分别显示起效和持续时间分别为7.5±1.3、62.5±5.9分钟。这种组合允许使用较低剂量的两种药物,以避免不良的副作用。对接研究揭示了良好的相互作用和与GABA A受体的BDZ结合位点的结合,尤其是与Arg87,Arg149和Thr151氨基酸残基的结合。
    DOI:
    10.1016/j.ejmech.2016.08.038
点击查看最新优质反应信息

文献信息

  • 6,7-DIHYDRO-[1,3,4]THIADIAZOLO-[3,2-a][1,3]DIAZEPIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS HYPNOTIC OR ANESTHETIC AGENT AND METHOD FOR THEIR PREPARATION
    申请人:Hassan Ghada S.
    公开号:US20140088090A1
    公开(公告)日:2014-03-27
    The present invention relates to a compound of formula 1, a pharmaceutical composition containing the compound, a method for its preparation as well as the use of the compound as hypnotic agent or anesthetic agent.
    本发明涉及一种化合物1的药物组成,包含该化合物的药物组成,以及该化合物作为催眠剂或麻醉剂的制备方法和使用。
  • 6,7-dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical compositions containing the same as hypnotic or anesthetic agent and method for their preparation
    申请人:Hassan Ghada S.
    公开号:US08741893B2
    公开(公告)日:2014-06-03
    The present invention relates to a compound represented by formula 1 or an addition salt thereof, a pharmaceutical composition containing the compound, a method for its preparation as well as the use of the compound as an hypnotic agent or anesthetic agent: wherein each symbol is as defined in the Specification.
    本发明涉及一种由式1表示的化合物或其加成盐,含有该化合物的药物组合物,其制备方法以及将该化合物用作催眠剂或麻醉剂的用途。其中,每个符号如规范中所定义。
  • 6,7-Dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical compositions containing the same as hypnotic or anesthetic agent and method for their preparation
    申请人:King Saud University
    公开号:EP2514753B1
    公开(公告)日:2013-08-21
  • [EN] 6,7-DIYDRO-[1,3,4]THIADIAZOLO-[3,2-A][1,3]DIAZEPIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS HYPNOTIC OR ANESTHETIC AGENT AND METHOD FOR THEIR PREPARATION<br/>[FR] DÉRIVÉS DE LA 6,7-DIHYDRO-[1,3,4] THIADIAZOLO-[3,2-A][1,3] DIAZÉPINE ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT EN TANT QU'AGENT HYPNOTIQUE OU ANESTHÉSIQUE ET PROCÉDÉ POUR LEUR PRÉPARATION
    申请人:UNIV KING SAUD
    公开号:WO2012136356A8
    公开(公告)日:2013-01-03
  • US8741893B2
    申请人:——
    公开号:US8741893B2
    公开(公告)日:2014-06-03
查看更多

同类化合物

雷唑巴占 唑美巴占 六氢-2-(硝基亚氨基)-1H-1,3-二氮杂卓 [1,3]恶唑并[3,2-a][1,3]二氮杂卓 7-苯基-3,4-二氢-1H-1,4-二氮杂革-5(2H)-酮 7,8-二氢-1-苯基-6H-吡啶并(3,2,1-jk)(1,4)苯并二氮杂卓-4(3H)-酮 5H-吡咯并[1,2-a][1,4]二氮杂卓 5-甲基-7-苯基-6,7-二氢-1H-1,4-二氮杂-2,3-二甲腈 5-三氟甲基-2,3-二氢-1H-1,4-二氮杂卓 5,7-二苯基-2,3,6,7-四氢-1H-1,4-二氮杂卓 5,7-二甲基-2,3-二氢-1H-[1,4]二氮杂卓高氯酸盐 4,5,6,7-四氢-1H-1,3-二氮杂卓-2-胺 3,5,7-三苯基-4H-1,2-二氮杂卓 2H-[1,3,5]恶二嗪o[3,2-a][1,3]二氮杂卓 2-甲基硫代-4,5,6,7-四氢-1H-[1,3]二氮杂卓 2-甲基-4,5,6,7-四氢-1H-1,3-二氮杂卓 2,3-二氢-5,7-双(三氟甲基)-1H-1,4-二氮杂卓 1-(5-甲氧基-1,4-二氮杂-1-基)乙酮 1,4,5,7,8,9,10,10A-八氢吡啶并[1,2-a][1,4]二氮杂卓 (9ci)-2,3-二氢-N,N-二甲基-1H-1,4-二氮杂卓-6-甲胺 (9ci)-1H-1,2-二氮杂卓-1-羧酸甲酯 (9ci)-1H,3h-噁唑并[3,4-d][1,4]二氮杂卓 (9ci)-1H,3h-噁唑并[3,4-a][1,4]二氮杂卓 1,7-di-(4-chlorophenyl)-3a,4a-dimethyl-3a,4a,8,13-tetrahydro-4H-bis[1,2,4-oxadiazolo][4,5-a:5',4'-d][1,5]benzodiazepine [1,4]diazepine-1-carboxylic acid tert-butyl ester 6-o-Chlorophenyl-8-ethyl-1,2-dihydro-4H-s-triazolo [3,4-c] thieno[2,3-e] [1,4]diazepin-1-one 2-(2-Dimethylaminoethyl)-6-o-chlorophenyl-8-ethyl-1,2-dihydro-4H-s-triazolo[3,4-c]thieno[2,3-e][1,4]diazepin-1-one 2-methyl-5-trifluoromethyl-2,3-dihydro-1,4-diazepine 3-methyl-5-trifluoromethyl-2,3-dihydro-1,4-diazepine 2,3-dihydro-2-methyl-6-nitro-1H-1,4-diazepine 1,4-dimethyl-7-((2,2-dimethylpropyl)amino)-1,2,3,4-tetrahydro-5H-1,4-diazepin-5-one 9-cetyl-3-methyl-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]diazepinium bromide Methyl 3,7-Diazabicyclo[5,4,0]undec-5-ene 1-N-tert-butoxycarbonyl-3-methoxy-6,6-dimethyl-1,4-diazepine trans-5,9a-dimethyl-5a,6,7,8,9,9a-hexahydro-1H-benzo[e]-1,4-diazepine-2,3-dicarbonitrile 2,3,4,5,7,9-hexahydro-9-methyl-9-(N-p-chlorophenylthio-carbamoyl)-[1,3]oxazolo[3,4-a][1,3]diazepin-7-one 2,3,4,5,7,9-hexahydro-9-methyl-9-(N-phenylthio-carbamoyl)-[1,3]oxazolo[3,4-a][1,3]diazepin-7-one 1,5-diazabicyclo [5.4.0] undecene 4,5,6,7-tetrahydro-2[2-(pyridin-4-yl)ethyl]-1H-1,3-diazepine 1,3-diazepane-2-selenone 2-[3]pyridyl-4,5,6,7-tetrahydro-1H-[1,3]diazepine 4,6-bis(trifluoromethyl)-2-isopropoxy-1H-1,3-diazepine 3-Methyl-8-(2-fluorophenyl)isoxazolo[4,3-e][1,4]-diazepin-5-one 4-(2-Diethylaminoethyl)-8-(2-fluorophenyl)-3-methylisoxazolo-[4,3-e][1,4]diazepin-5-one 2,3a,5,5-tetramethyl-3a,4,5,6-tetrahydrothiazolo[3,2-a][1,5]-benzodiazepin-1(2H)-one pyrrolo[1,2-a][1,4]diazepine 2H-1,3-Diazepine 36KJ536Yay N-octadecyl-4,5,6,7-tetrahydro-1H-1,3-diazepin-2-amine;hydroiodide N-decyl-4,5,6,7-tetrahydro-1H-1,3-diazepin-2-amine;hydroiodide